City

Houston (1)

Manhasset (1)

New York (1)

Seattle (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

AstraZeneca (1)

Intervention

best practice (1)

danvatirsen (1)

durvalumab (1)

internet-based intervention (1)

questionnaire administration (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

refractory lung carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting

Advanced Colorectal Carcinoma
+24 more

Danvatirsen
Durvalumab

Houston, Texas

M D Anderson Cancer Center

Oct 20, 2022

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma

Not yet recruiting

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
+45 more

Internet-Based Intervention
+2 more

Manhasset, New York
+3 more

Mar 30, 2022